Next |
home / stock / innmf / innmf message board
Subject | By | Source | When |
---|---|---|---|
Renee Thank you. | Echo20 | investorshub | 10/09/2018 8:23:47 PM |
Since Amplia Therapeutics Ltd. is not registered with | Renee | investorshub | 10/09/2018 7:00:48 PM |
Amiran Do post when you know. Echo20 | Echo20 | investorshub | 10/09/2018 6:25:58 PM |
Renee Do you have the total share count? Echo20 | Echo20 | investorshub | 10/09/2018 6:24:18 PM |
Innate Immunotherapeutics Ltd. changed to Amplia Therapeutics Ltd.: | Renee | investorshub | 09/12/2018 8:43:38 PM |
Hope he goes to jail for years. This | Penny Masters | investorshub | 08/09/2018 2:30:40 AM |
https://www.msn.com/en-us/news/us/new-york-gop-rep-chris-collins-arrested-on-ins | tigerpac | investorshub | 08/08/2018 5:53:50 PM |
15 shares of this traded today? | Smilin_B | investorshub | 05/18/2018 1:44:40 AM |
ETrade shares on hold - The last couple | amiran | investorshub | 05/17/2018 11:33:36 PM |
all true | amiran | investorshub | 05/10/2018 11:30:10 PM |
My point is that this stock didnt close | Smilin_B | investorshub | 05/10/2018 10:54:03 PM |
I listened to the shareholder conference call. The | amiran | investorshub | 05/10/2018 10:46:49 PM |
This has got to be one of the | Smilin_B | investorshub | 05/10/2018 9:03:45 PM |
That's kind of what I figured, but then | amiran | investorshub | 05/09/2018 8:23:00 PM |
Itll price equal to the market cap on | deadjim | investorshub | 05/09/2018 8:20:01 PM |
how/when? Do you mean the market will force | amiran | investorshub | 05/09/2018 2:59:43 PM |
Itll adjust to the correct price. | deadjim | investorshub | 05/09/2018 3:29:37 AM |
I got the new shares today and was | amiran | investorshub | 05/07/2018 8:28:08 PM |
Yes lol. Have you gotten your new shares yet? | LexTrader | investorshub | 05/04/2018 4:44:34 PM |
Is this not the most screwed up reverse | Smilin_B | investorshub | 05/04/2018 4:43:00 PM |
News, Short Squeeze, Breakout and More Instantly...
Amplia Therapeutics Ltd Company Name:
INNMF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Amplia Therapeutics Ltd (ASX:ATX) CEO Chris Burns joins Proactive’s Jonathan Jackson to discuss the company’s busy quarter and what investors can expect over the coming months. Burns talks us through the completion of the Phase1B stage of the ACCENT clinical trial i...
(NewsDirect) Amplia Therapeutics Ltd (ASX:ATX) CEO Dr Chris Burns tells Proactive the company has received grant funding to undertake a research collaboration with Australia’s national science agency to develop topical formulations of its FAK inhibitors. Amplia will work with resea...
(NewsDirect) Amplia Therapeutics Ltd (ASX:ATX) CEO Dr Chris Burns speaks with Proactive following his move into the leadership role late last year. Amplia is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an ...